3,4‐diaminopyridine base effectively treats the weakness of Lambert‐Eaton myasthenia

Introduction: 3,4‐diaminopyridine has been used to treat Lambert‐Eaton myasthenia (LEM) for 30 years despite the lack of conclusive evidence of efficacy. Methods: We conducted a randomized double‐blind placebo‐controlled withdrawal study in patients with LEM who had been on stable regimens of 3,4‐di...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Muscle Nerve
Asıl Yazarlar: Sanders, Donald B., Juel, Vern C., Harati, Yadollah, Smith, A. Gordon, Peltier, Amanda C., Marburger, Tessa, Lou, Jau‐Shin, Pascuzzi, Robert M., Richman, David P., Xie, Tai, Demmel, Valentin, Jacobus, Laura R., Aleš, Kathy L., Jacobus, David P.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2018
Konular:
Clinical Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5900968/
https://ncbi.nlm.nih.gov/pubmed/29280483
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mus.26052
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller